The impact of the Trump administration’s decision to cut more than half of South Africa’s HIV and TB projects extends beyond diminished access to HIV testing and treatment drugs; it also complicates the provision of care for noncommunicable diseases (NCDs). This reduction in funding will likely exacerbate health challenges in a country already facing significant disease burdens. As a result, the overall health landscape in South Africa may suffer, limiting the effectiveness of public health initiatives aimed at combating both infectious and chronic diseases.
Full Article
Loading PerspectiveSplit analysis...






